CAD 0.03
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 1.05 Million | 1.67 Million | 939.79 Thousand | 710.63 Thousand | 1.16 Million | 1.21 Million |
Selling, General and Administrative Expenses | 771.45 Thousand | 1.67 Million | 939.79 Thousand | 710.63 Thousand | 1.16 Million | 1.21 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | 105.58 Thousand | - | - | 29.36 Thousand |
Cost and Expenses | 1.05 Million | 1.67 Million | 939.79 Thousand | 710.63 Thousand | 1.16 Million | 1.21 Million |
Operating Income | -771.45 Thousand | -6.73 Million | -3.41 Million | -710.64 Thousand | -1.4 Million | -1.18 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | -5.06 Million | -2.47 Million | -425.30 | -246.06 Thousand | 29.34 Thousand |
Earnings before Tax | -2.24 Million | 3.38 Million | 1.63 Million | 4.16 Million | -917.83 Thousand | -2.53 Million |
Net Income | -2.24 Million | 3.38 Million | 1.63 Million | 4.16 Million | -917.83 Thousand | -2.53 Million |
Earnings Per Share Basic | -0.01 | 0.02 | 0.01 | 0.03 | -0.01 | -0.03 |
Earnings Per Share Diluted | -0.01 | 0.02 | 0.01 | 0.03 | -0.01 | -0.03 |
Weighted Average Shares Outstanding | 223.13 Million | 204.21 Million | 162.05 Million | 139.17 Million | 116.94 Million | 92.84 Million |
Weighted Average Shares Outstanding (Diluted) | 223.11 Million | 204.21 Million | 164.85 Million | 139.17 Million | 116.94 Million | 92.84 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | -1.1 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 750.00 | 750.00 | 1500.00 | - | - | - |
Gross Profit | -750.00 | -750.00 | -1500.00 | - | - | - |
Operating Expenses | 180.46 Thousand | 216.8 Thousand | 223.2 Thousand | 1.05 Million | 223.96 Thousand | 290.75 Thousand |
Selling, General and Administrative Expenses | 180.46 Thousand | 216.8 Thousand | 223.2 Thousand | - | 199.96 Thousand | 290.75 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | 71.56 Thousand | - | - |
Cost and Expenses | 181.21 Thousand | 217.55 Thousand | 224.7 Thousand | 1.05 Million | 223.96 Thousand | 290.75 Thousand |
Operating Income | -181.21 Thousand | -217.55 Thousand | -288.96 Thousand | 202.93 Thousand | -441.07 Thousand | 505.96 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | - | -65.75 Thousand | 1.25 Million | -217.3 Thousand | 796.48 Thousand |
Earnings before Tax | -878.61 Thousand | 1.21 Million | -160.45 Thousand | -2.24 Million | 64.7 Thousand | -1.08 Million |
Net Income | -878.61 Thousand | 1.21 Million | -160.45 Thousand | -2.24 Million | 64.7 Thousand | -1.08 Million |
Earnings Per Share Basic | -0.00 | 0.01 | -0.00 | - | 0.00 | -0.00 |
Earnings Per Share Diluted | -0.00 | 0.01 | -0.00 | - | 0.00 | -0.00 |
Weighted Average Shares Outstanding | 236.43 Million | 234.16 Million | 226.59 Million | 223.11 Million | 226.59 Million | 224.36 Million |
Weighted Average Shares Outstanding (Diluted) | 236.43 Million | 234.16 Million | 226.59 Million | 223.11 Million | 226.59 Million | 224.36 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -180.46 Thousand | -216.8 Thousand | -288.96 Thousand | - | -441.07 Thousand | 505.96 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
CEBUY
BIOF
GBBFF
3569
NGG
HITI